Résumé
Objetivo: conhecer as representações sociais sobre o planejamento reprodutivo entre mulheres em gravidez não planejada na Estratégia Saúde da Família. Método: estudo qualitativo, orientado pela Teoria das Representações Sociais, realizado com 15 gestantes, entre abril e maio de 2019. Utilizou-se a entrevista semiestruturada. Os dados foram organizados por meio do Discurso do Sujeito Coletivo, com auxílio do software DSCsoft©. Protocolo de pesquisa aprovado pelo Comitê de Ética em Pesquisa. Resultados: as representações sociais das mulheres em gravidez não planejada evidenciadas pelo Discurso do Sujeito Coletivo foram representadas por oito ideias centrais, a saber: "eu não me preveni, nem ele", "nós nos prevenimos", "eu comprava", "pegava no posto", "construir uma família", "ter esse acesso", "estou por fora" e "eu sei que é disponível". Conclusão: as representações sociais nos discursos das mulheres em gravidez não planejada estavam pautadas no desconhecimento acerca do planejamento reprodutivo, dos anticoncepcionais disponíveis e seu uso correto.
Objective: to understand the social representations of reproductive planning among women with unplanned pregnancies in the Family Health Strategy. Method: qualitative study, guided by the Theory of Social Representations, carried out with 15 pregnant women between April and May 2019. Semi-structured interviews were used. The data was organized using the Discourse of the Collective Subject, with the aid of DSCsoft© software. Research protocol approved by the Research Ethics Committee. Results: the social representations of women with unplanned pregnancies as evidenced by the Collective Subject Discourse were represented by eight central ideas, namely: "I didn't prevent myself, nor did he", "we prevented ourselves", "I would buy it", "I would get it at the health center", "build a family", "have this access", "I am not aware" and "I know it is available". Conclusion: the social representations in the women's speeches about unplanned pregnancies were based on a lack of knowledge about reproductive planning, the contraceptives available and their correct use.
Objetivo: conocer las representaciones sociales sobre la planificación reproductiva de las mujeres con embarazo no planificado en la Estrategia Salud de la Familia. Método: estudio cualitativo, basado en la Teoría de las Representaciones Sociales, realizado con 15 mujeres embarazadas, entre abril y mayo de 2019. Se utilizaron entrevistas semiestructuradas. Los datos fueron organizados mediante el Discurso del Sujeto Colectivo, con ayuda del software DSCsoft©. El protocolo de investigación fue aprobado por el Comité de Ética en Investigación. Resultados: las representaciones sociales de las mujeres con embarazo no planificado reveladas por el Discurso del Sujeto Colectivo fueron representadas por ocho ideas centrales, a saber: "yo no me cuidé y él tampoco", "nos cuidamos", "yo los compraba", "los buscaba en el centro de salud", "construir una familia", "tener acceso", "no participo" y "sé que está disponible". Conclusión: las representaciones sociales en los discursos de las mujeres con embarazo no planificado se basaron en la falta de conocimiento sobre la planificación reproductiva, en los anticonceptivos disponibles y su uso correcto.
Résumé
Se ha señalado al uso de los métodos anticonceptivos hormonales como una de las posibles causas que explican el exceso de depresión en mujeres. Objetivo: Explorar la literatura sobre la asociación entre uso de anticoncepción hormonal y depresión en adolescentes y jóvenes. Método: Se llevó a cabo una revisión de alcance de la literatura identificando estudios empíricos cuantitativos enfocados en la asociación entre uso de anticonceptivos hormonales y depresión en mujeres entre 11 y 24 años, publicados entre enero de 2017 y septiembre de 2022 e indexadas en Web of Science y SCOPUS. Resultados: Se incluyeron 12 artículos que mostraron asociaciones positivas, negativas y no concluyentes o con resultados mixtos. Conclusiones: La relación entre el uso de anticonceptivos hormonales y depresión es compleja y multifacética. Los resultados presentados resaltan la necesidad de una investigación continua y más específica para comprender mejor las posibles asociaciones y proporcionar orientación clínica más precisa.
Abstract. The use of hormonal contraceptive methods has been pointed out as one of the possible causes that explain the excess of depression in women. Objective: To explore the literature on the association between the use of hormonal contraceptives and depression in adolescents and young women. Methods: We conducted a scoping review of the literature identifying quantitative empirical studies focused on the association between hormonal contraceptive use and depression in women aged 11-24 years, published between January 2017 and September 2022, and indexed in Web of Science and SCOPUS. Results: In total, 12 articles showing positive, negative, and inconclusive or mixed associations were included. Conclusions: The relationship between hormonal contraceptive use and depression is complex and multifaceted. The results presented highlight the need for continued and more specific research to better understand possible associations and provide more accurate clinical guidance.
Sujets)
Humains , Femelle , Enfant , Adolescent , Adulte , Jeune adulte , Contraceptifs oraux hormonaux , Dépression/psychologieRésumé
ObjectiveTo investigate the use of contraceptive methods, and to evaluate maternal healthcare services utilization among women within 2 years in Pudong New Area of Shanghai. MethodsA cross-sectional survey was conducted using a questionnaire for women at different postpartum periods who visited a community health clinic with their children from June to November 2021. Data were analyzed using χ2 test and binary logistic regression. ResultsAmong the 1 946 postpartum women surveyed, 1 934 were either married or cohabiting, and1 430 had resumed their sexual life. Among women at 4, 6, 12, 18 and 24 months postpartum, the contraceptive prevalence rates (CPR) were 92.34% (193/209), 92.16% (235/255), 87.31% (282/323), 91.95% (297/323) and 90.00% (288/320), respectively. The modern contraceptive prevalence rates (mCPR) were 87.08% (182/209), 87.06% (222/255), 82.04% (265/323), 83.09% (271/323) and 85.31% (273/320), respectively, while the unmet contraceptive needs (UMNs) were 7.66% (16/209), 7.84% (20/255), 11.46% (37/323), 6.81% (22/323) and 10.00% (32/320), respectively. The use rates of long-acting reversible contraceptive (LARC) methods among women at 6, 12, 18 and 24 months postpartum period were 0.39% (1/255), 2.17% (7/323), 0.31% (1/323), and 2.81% (9/320), respectively. Among all surveyed subjects, 32.17% (626/1 946) had received postpartum contraceptive services only once, while 27.85% (542/1 946) had not received any postpartum contraceptive services. Binary logistic regression analysis indicated that the use of contraceptive methods among postpartum women was associated with whether relevant educational services were received after childbirth and during postpartum home visits (all P<0.05). ConclusionPostpartum women have unmet needs for contraception. Contraceptive guidance at the 42-day postnatal healthcare visit needs to be further strengthened and postpartum contraceptive education could be integrated into the pregnancy care. The quality and effectiveness of contraceptive education during delivery and postpartum home visits, and even at the 42-day postnatal healthcare visit need to be further explored.
Résumé
ABSTRACT Objectives: to synthesize and analyze evidence on intrauterine device insertion by nurses in Primary Health Care. Methods: an integrative review, carried out in the BDENF, CINAHL, LILACS, SciELO, Scopus, PubMed and Web of Science databases in June 2022, delimiting the period from 1960 to 2022. Results: 141 articles were identified in the initial search, and 10 studies made up the final sample. Four (40%) were developed in the United States and one (10%) in Brazil, with publications from 1979 to 2021. The findings were grouped into three categories: Nurse training to insert an intrauterine device; Nurses' competency to insert an intrauterine device; and Women's access to intrauterine devices. Conclusions: nurse theoretical and practical training is a prominent element, consolidated in the favorable outcomes of insertions performed by nurses and satisfaction among women, a practice that has expanded access to the contraceptive method in Primary Health Care.
RESUMEN Objetivos: sintetizar y analizar la evidencia sobre la inserción de dispositivos intrauterinos por parte de enfermeras en la Atención Primaria de Salud. Métodos: revisión integrativa, realizada en las bases de datos BDENF, CINAHL, LILACS, SciELO, Scopus, PubMed y Web of Science en junio de 2022, delimitando el período de 1960 a 2022. Resultados: se identificaron 141 artículos en la búsqueda inicial y 10 publicaciones conformaron la muestra final. Cuatro (40%) fueron desarrollados en Estados Unidos y uno (10%) en Brasil, con publicaciones de 1979 a 2021. Los hallazgos se agruparon en tres categorías: Capacitación de enfermeras para insertar un dispositivo intrauterino; Competencia de las enfermeras para insertar un dispositivo intrauterino; y Acceso de las mujeres a los dispositivos intrauterinos. Conclusiones: la formación teórica y práctica de los enfermeros es un elemento destacado, consolidado en los resultados favorables de las inserciones realizadas por los enfermeros y la satisfacción de las mujeres, práctica que ha ampliado el acceso al método anticonceptivo en la Atención Primaria de Salud.
RESUMO Objetivos: sintetizar e analisar as evidências da inserção de dispositivo intrauterino por enfermeiros na Atenção Primária à Saúde. Métodos: revisão integrativa, realizada nas bases de dados BDENF, CINAHL, LILACS, SciELO, Scopus, PubMed e Web of Science em junho de 2022, delimitando-se o período de 1960 a 2022. Resultados: identificaram-se 141 artigos na busca inicial, e 10 publicações compuseram a amostra final. Quatro (40%) foram desenvolvidos nos Estados Unidos e um (10%) no Brasil, sendo publicações de 1979 a 2021. Os achados foram agrupados em três categorias: Treinamento dos enfermeiros para inserção de dispositivo intrauterino; Competência dos enfermeiros para inserção de dispositivo intrauterino; e Acesso das mulheres aos dispositivos intrauterinos. Conclusões: o treinamento teórico e prático dos enfermeiros é um elemento de destaque, consolidado nos desfechos favoráveis das inserções realizadas por enfermeiros e satisfação entre as mulheres, prática que tem ampliado o acesso ao método contraceptivo na Atenção Primária à Saúde.
Résumé
ABSTRACT Introduction: Female participation in sports has reached a milestone in 1972 when a constitutional amendment was implemented to ensure equal opportunities for men and women. Since then, the percentage of participants in competitive sports has grown. In this context became necessary to understand menstrual cycle, contraceptive use, and its individual responses. Objective: To investigate menstrual cycle characteristics, physical and mood symptoms related to vaginal bleeding, and contraceptives used by Brazilian Olympic athletes. Also, to assess if these athletes relate that vaginal bleeding influences sportive performance, how they manage it and what can be changed to improve their health care and sportive performance. Additionally, we propose specialized female care by a gynaecologist specialized in sports medicine. Methods: Descriptive observational study was conducted from July to August 2016 and included 118 Brazilian Olympic female athletes, in menacme. The athletes completed a self-administered online questionnaire, adapted from Pre-Participation Gynaecological Examination of female athletes. Results: Participants practiced 28 different sports, mean age 27 ± 4.7 years. For 66% it was their first participation in an Olympic Game. Most used contraceptives (54%), mainly oral (61%). Most (76%) believed that vaginal bleeding influenced sports performance, and 63% preferred to compete after bleeding cessation. Fifty-eight percent would compete at preferred time of their cycle. Anxiety symptoms, bloating, increased appetite, depression, and dysmenorrhea were indicated by 52%. Among these, 49% reported that these symptoms deteriorated their sportive performance. Conclusion: Most in their first Olympic participation, Brazilian athletes used hormone contraceptives, mainly oral ones to manage and adapt their vaginal bleeding to the competition calendar because most of them referred those physical and mood symptoms deteriorated their sportive performance. The presence of a Sportive Gynaecologist as part of the Olympic Medical Staff highlighted the female athletes issues and helped them to improve sportive performance. Level of Evidence IV; Cross-sectional observational study
RESUMEN Introducción: La participación femenina en deportes alcanzó un hito en 1972, cuando se implementó una reforma constitucional para garantizar igualdad de oportunidades entre hombres y mujeres. Desde entonces, el porcentaje de participantes en deportes competitivos ha crecido. En este contexto, se hizo necesario comprender el ciclo menstrual, el uso de anticonceptivos y sus respuestas individuales. Objetivo: Investigar características del ciclo menstrual, síntomas físicos, estado de ánimo, quejas relacionadas con el sangrado vaginal y los métodos anticonceptivos utilizados por atletas olímpicas brasileñas. Evaluar si estas deportistas perciben influencia del sangrado vaginal en el rendimiento deportivo, cómo lo controlan y qué se puede cambiar para mejorar. Además, ofrecemos atención especializada por una ginecóloga especialista en medicina deportiva. Métodos: Estudio observacional, descriptivo, realizado de julio a agosto de 2016, que incluyó 118 atletas olímpicas brasileñas, en menacme. Las atletas respondieron un cuestionario en línea autoadministrado y adaptado titulado "Examen ginecológico previo a la participación". Resultados: Practicaban 28 deportes diferentes, con edad media = 27 ± 4,7 años. Para 66%, era su primera participación en un juego olímpico. Anticonceptivos usados r54%), principalmente orales (61%). La mayoría (76%) cree que el sangrado vaginal influye en el rendimiento deportivo y 63% prefirió competir después del. El 58% de los atletas competiría en su momento preferido de su ciclo. Los síntomas de ansiedad, hinchazón, aumento del apetito, depresión y dismenorrea fueron indicados por el 52%. Entre estas, 49% deterioró su rendimiento deportivo. Conclusión: En su primera participación olímpica, las atletas brasileñas utilizaron anticonceptivos hormonales, principalmente orales, para controlar y adaptar el sangrado vaginal al calendario de competición, ya que la mayoría relató que los síntomas físicos y anímicos perjudicaban su desempeño deportivo. La presencia de una Ginecóloga Deportiva como parte del Equipo Médico Olímpico destacó los problemas de las atletas y las ayudó a mejorar su rendimiento. Nivel de Evidencia IV; Estudio Observacional.
RESUMO Introdução: A participação feminina no esporte teve um marco importante em 1972, quando uma emenda constitucional foi implementada para garantir a igualdade de oportunidades para homens e mulheres. Desde então, o percentual de participantes em esportes competitivos tem crescido. Nesse contexto tornou-se necessário compreender sobre ciclo menstrual, uso de anticoncepcionais e suas respostas individuais. Objetivo: Investigar características do ciclo menstrual, sintomas físicos e de humor, queixas relacionadas ao sangramento vaginal e métodos contraceptivos usados por atletas olímpicas brasileiras. Avaliar se percebem influência do sangramento vaginal no desempenho esportivo, como elas o controlam e o que pode ser mudado para melhorar seus cuidados e desempenho esportivo. Além disso, propõe-se atendimento específico por ginecologista especializada em medicina esportiva. Métodos: Estudo observacional, descritivo, realizado de julho a agosto de 2016 que incluiu 118 atletas olímpicas brasileiras, na menacme. As atletas responderam a um questionário online autoaplicável e adaptado intitulado "Pre-Participation Gynaecological Examination". Resultados: As participantes praticavam 28 esportes diferentes, com média de idade = 27 ± 4,7 anos. Para 66%, foi a primeira participação em um evento olímpico. A maioria usava anticoncepcional (54%), principalmente oral (61%). A maioria (76%) acredita que o sangramento vaginal influencia o desempenho esportivo e 63% preferiam competir após o mesmo. 58% das atletas competiriam no momento preferido de seu ciclo. Sintomas de ansiedade, distensão abdominal, aumento do apetite, depressão e dismenorreia foram indicados por 52%. Entre esses, 49% deterioraram o desempenho esportivo. Conclusão: Em sua primeira participação olímpica, as atletas brasileiras utilizaram anticoncepcionais hormonais, principalmente orais, para controlar e adaptar o sangramento vaginal ao calendário de competição, pois a maioria referiu que os sintomas físicos e de humor prejudicaram o desempenho esportivo. A presença de uma Ginecologista Esportiva como parte da Equipe Médica Olímpica destacou os problemas das atletas femininas e as ajudou a melhorar o desempenho esportivo. Nível de Evidência IV; Estudo Observacional.
Résumé
Resumo Este artigo apresenta resultados da pesquisa socioantropológica "Jovens da era digital: sexualidade, reprodução, redes sociais e prevenção às IST/HIV/aids", conduzida com interlocutores (as) de 16 a 24 anos em seis cidades brasileiras. Analisamos narrativas de jovens heterossexuais, especialmente mulheres, dada a centralidade da posição que ocupam no planejamento reprodutivo em contextos hierárquicos de gênero. Apresentamos um script típico da contracepção juvenil: uso de preservativo na iniciação sexual, seguido de método hormonal em combinação/ou não com coito interrompido e o recurso frequente à contracepção de emergência. Destaca-se a experiência negativa das mulheres diante dos efeitos colaterais da contracepção hormonal, resultando em seu abandono ou descontinuidade, bem como o interesse pelo DIU de cobre que, no entanto, é considerado pouco acessível no Sistema Único de Saúde (SUS). Concluímos que, a despeito de constrangimentos de gênero e de desigualdades sociais, étnicas e raciais, a contracepção é um valor incorporado pelos(as) entrevistados(as), aspecto que deve ser considerado na atualização e retomada de políticas públicas voltadas à juventude.
Abstract This study presents the findings of the social anthropological research project "Jovens da era digital: Sexualidade, reprodução, redes sociais e prevenção às IST/HIV/AIDS" [Young people in the digital age: Sexuality, reproduction, social media, and prevention of STI/HIV/AIDS], which was conducted with interlocutors between the ages of 16 and 24 years old from six Brazilian cities. This study focuses on contraceptive management among heterosexual adolescents and young adults, with particular emphasis on women, given their prominent role in family planning within hierarchical gender contexts. We describe the typical script for youth contraception, which involves the use of condoms at the onset of sexual activity, followed by the incorporation of hormonal methods or the withdrawal method. We also find that adolescents frequently resort to the use of emergency contraception. Women frequently report experiencing side effects from hormonal contraceptives, which results in high rates of discontinuation and an increased interest in copper IUDs, which are scarce resources within the Brazilian National Health System. It can be concluded that, despite gender constraints and social, ethnic, and racial inequalities, the interviewees value contraception, offering insights for the review and improvement of public policies concerning young people.
Sujets)
Humains , Mâle , Femelle , Adolescent , Contraception , Sexualité , Droits procréatifs , Identité de genre , BrésilRésumé
Abstract Objective: To explore women's experiences with postpartum intrauterine device (PPIUD) insertion and the decision-making process in the postpartum period. Methods: A qualitative design was employed with face-to-face interviews using a semi-structured script of open questions. The sample was intentionally selected using the concept of theoretical information saturation. Results: Interviews were conducted (1) in the immediate postpartum period, and (2) in the postpartum appointment. 25 women (N = 25) over 18 years old who had a birth followed by PPIUD insertion were interviewed between October 2021 and June 2022. Three categories were constructed: (1) Choice process, (2) Relationship with the health team at the time of birth and the postpartum period, and (3) To know or not to know about contraception, that is the question. Conclusion: Professionals' communication management, popular knowledge, advantages of the PPIUD and the moment PPIUD is offered play a fundamental role in the construction of knowledge about the IUD. Choice process did not end in the insertion.
Sujets)
Humains , Femelle , Grossesse , Période du postpartum , Santé reproductive , Contraception réversible à action prolongée , Dispositifs intra-utérinsRésumé
Objectives: to develop a serious game in a mobile application for learning about safe sex and contraception with the active participation of adolescents; and evaluate the content, appearance and usability of the technology with adolescents and experts. Method: this is an applied research project into the development of a serious game, carried out in two stages: development of the technology itself; and evaluation of the content, appearance and usability of the application. Teenagers from a public school in the city of São Paulo-Brazil took part in the technology development stage. The evaluation was carried out by the adolescents and experts in the areas of public health and health technology. The following criteria were used: educational aspects, environment interface and didactic resources. Results: Prinventon App ® was developed, a serious game set in a virtual city, designed to address adolescent sexuality. The app received 90% positive responses and had a Content Validity Index of 0.80, which was considered adequate. The suggestions and notes were accepted and implemented. The serious game was considered interesting and important in terms of the subject matter. Conclusion: it was found that the technology developed can help adolescents learn about safe sex and contraception, by addressing sexuality in adolescence in a playful and realistic way.
Objetivos: desarrollar un serious game en aplicación móvil para el aprendizaje sobre sexo seguro y anticoncepción con la participación activa de los adolescentes; y evaluar contenido, apariencia y usabilidad de la tecnología con adolescentes y expertos. Método: se trata de una investigación aplicada, de producción tecnológica acerca del desarrollo de un serious game , realizada en dos etapas: desarrollo de la tecnología propiamente dicha; y evaluación del contenido, apariencia y usabilidad de la aplicación. Adolescentes de una escuela pública de la ciudad de São Paulo-Brasil participaron en la etapa de desarrollo de la tecnología. Ya la evaluación fue hecha por los adolescentes y expertos en las áreas de salud colectiva y tecnología en salud. Se siguieron los criterios: aspectos educacionales, interfaz del ambiente y recursos didácticos. Resultados: se desarrolló Prinventon App ® , un serious game ambientado en una ciudad virtual, diseñado para abordar la sexualidad en la adolescencia. La aplicación obtuvo 90% de respuestas positivas y presentó Índice de Validez de Contenido de 0,80, siendo considerado adecuado. Las sugerencias y apuntes fueron acogidos e implementados. El serious game fue considerado interesante e importante ante el tema abordado. Conclusión: la tecnología desarrollada puede ayudar a los adolescentes en el aprendizaje sobre sexo seguro y anticoncepción, al apuntar abordar, de manera lúdica y realista, la sexualidad en la adolescencia.
Objetivos: desenvolver um serious game em aplicativo mobile para aprendizagem sobre sexo seguro e contracepção com a participação ativa dos adolescentes; e avaliar conteúdo, aparência e usabilidade da tecnologia com adolescentes e experts . Método: trata-se de uma pesquisa aplicada, de produção tecnológica sobre o desenvolvimento de um serious game , realizada em duas etapas: desenvolvimento da tecnologia propriamente dita; e avaliação do conteúdo, aparência e usabilidade do aplicativo. Adolescentes de uma escola pública da cidade de São Paulo-Brasil participaram da etapa de desenvolvimento da tecnologia . A avaliação foi realizada pelos adolescentes e experts nas áreas de saúde coletiva e tecnologia em saúde. Seguiram-se os critérios: aspectos educacionais, interface do ambiente e recursos didáticos. Resultados: desenvolveu-se Prinventon App ® , um serious game ambientado em uma cidade virtual, projetado para abordar a sexualidade na adolescência. O aplicativo obteve 90% de respostas positivas e apresentou Índice de Validade de Conteúdo de 0,80, sendo considerado adequado. As sugestões e apontamentos foram acatados e implementados. O serious game foi considerado interessante e importante diante do tema abordado. Conclusão: a tecnologia desenvolvida pode auxiliar os adolescentes na aprendizagem sobre sexo seguro e contracepção, ao abordar, de maneira lúdica e realística, a sexualidade na adolescência.
Sujets)
Humains , Femelle , Adolescent , Santé de l'adolescentRésumé
Resumen OBJETIVO: Determinar la frecuencia de aceptación y los factores asociados con la anticoncepción moderna posaborto en pacientes atendidas en un hospital público de Perú. MATERIALES Y MÉTODOS: Estudio observacional y transversal efectuado en pacientes en el posaborto inmediato atendidas de junio a diciembre de 2022 en el servicio de Urgencias del Hospital San Juan de Lurigancho, Lima, Perú, seleccionadas por conveniencia. Se utilizó un cuestionario validado. Se aplicó la prueba χ2 de Pearson con un nivel de significación del 5%. RESULTADOS: Se estudiaron 166 pacientes en el posaborto inmediato de las que el 94% (n = 156) aceptó algún método anticonceptivo moderno; el más frecuente fue el inyectable mensual (44.0%) y el menos aceptado el dispositivo intrauterino (0.6%). Los factores personales asociados con la aceptación del método anticonceptivo moderno fueron: edad (p < 0.01), no tener pareja (p < 0.001) y ésta estuviera de acuerdo con el anticonceptivo elegido (p < 0.001). Los factores institucionales asociados fueron: tiempo de la consejería en planificación familiar (p = 0.047), privacidad-confidencialidad de la consejería (p < 0.001) y satisfacción con la atención ofrecida durante la orientación (p = 0.026). CONCLUSIONES: La edad, carecer de pareja y estar de acuerdo con ésta acerca de la elección del método anticonceptivo posaborto junto con los factores institucionales (tiempo de consejería en planificación familiar, importancia de la privacidad-confidencialidad y percepción de la atención en consejería en planificación familiar) se asociaron, significativamente, con la aceptación de algún método anticonceptivo moderno posaborto.
Abstract OBJECTIVE: To determine the frequency of acceptance and factors associated with modern postabortion contraception in patients attended at a public hospital in Peru. MATERIALS AND METHODS: Observational and cross-sectional study conducted in immediate postabortion patients attended from June to December 2022 at the Emergency Department of the Hospital San Juan de Lurigancho, Lima, Peru, selected by convenience. A validated questionnaire was used. Pearson's test c2 was used with a significance level of 5%. RESULTS: We studied 166 patients in the immediate postabortion period, of whom 94% (n = 156) accepted some modern contraceptive method; the most common was the monthly injectable (44.0%) and the least accepted was the intrauterine device (0.6%). Personal factors associated with modern contraceptive method acceptance were age (p < 0.01), no partner (p < 0.001), and partner's agreement with the chosen contraceptive method (p < 0.001). Associated institutional factors were agreeing with the time of family planning counseling (p = 0.047), considering the importance of privacy-confidentiality of counseling (p < 0.001), and agreeing with the care offered during counseling (p = 0.026). CONCLUSIONS: Age, lack of a partner, and agreeing with the partner about the choice of postabortion contraceptive method along with institutional factors (time of family planning counseling, importance of privacy-confidentiality, and perception of care in family planning counseling) were significantly associated with acceptance of some modern postabortion contraceptive method.
Résumé
Los anticonceptivos orales combinados constituyen hoy en día uno de los métodos anticonceptivos más populares a nivel mundial. Su composición consiste en una combinación de análogos de hormonas sexuales femeninas que se administran en bajas dosis diarias, manteniendo constante su concentración sanguínea y evitando de esta forma los cambios en el eje endócrino que estimulan la ovulación. Con el objetivo de recrear los procesos fisiológicos, la mayoría de las formulaciones comprenden un intervalo de 4 a 7 días libres de hormonas en el cual se genera el sangrado por deprivación.A partir de una viñeta clínica en la que una paciente sana desea posponer su hemorragia por deprivación, y tras realizar una búsqueda bibliográfica que prioriza las investigaciones más recientes y de mejor calidad, la autora revisa la evidencia sobre el uso de hormonas sin intervalo libre, especialmente su efectos sobre la eficacia y la incidencia de efectos adversos. (AU)
Nowadays, combined oral contraceptives are one of the most popular contraceptive methods worldwide. Its composition consists of a combination of similar female sex hormones administered in low daily doses, keeping their blood concentration constant and thus avoiding changes in the endocrine axis that stimulate ovulation. In order to recreate physiological processes, most formulations include an interval of 4 to 7 hormone-free days in which withdrawal bleeding occurs.Starting from a clinical vignette in which a healthy patient desires to postpone her withdrawal bleeding, and after conducting a bibliographic search that prioritizes the most recent and best-quality research, the author reviews the evidence about the use of hormones without free interval, especially their effects on efficacy and the incidence of adverse effects. (AU)
Sujets)
Humains , Femelle , Adulte , Lévonorgestrel/administration et posologie , Contraceptifs oraux combinés/administration et posologie , Éthinyloestradiol/administration et posologie , Cycle menstruel/effets des médicaments et des substances chimiques , Calendrier d'administration des médicaments , Essais contrôlés randomisés comme sujet , Lévonorgestrel/effets indésirables , Contraceptifs oraux combinés/effets indésirables , Éthinyloestradiol/effets indésirables , Efficacité contraceptive , Revues systématiques comme sujet , Menstruation/effets des médicaments et des substances chimiquesRésumé
Objetivos: Describir la prevalencia de las interrupciones voluntarias del embarazo (IVE) recurrentes y efectuar una exploración de los factores asociados a esta. Materiales y métodos: Estudio de corte trasversal descriptivo, en el que se incluyeron mujeres atendidas entre 2015 y 2021 en cinco sedes, en el Departamento de Antioquia, de una Institución que promueve la atención en salud sexual y reproductiva (SSR) en Colombia. Se midieron variables sociodemográficas, de SSR, así como la realización de IVE recurrente, tipo de procedimiento utilizado en la primera IVE, y método de anticoncepción elegido posterior a esta. Se presenta la prevalencia de período de aborto recurrente global y por año. Se hace exploración de los factores asociados por medio de análisis multivariado. Se obtuvo aval del comité de investigación de la institución. Resultados: Se incluyó un total de 20.423 mujeres. La prevalencia de IVE recurrente fue del 4,07 % (n = 831) en todo el período, y varió del 2,3 al 6 % en los 6 años. El método más utilizado para la IVE recurrente fue inducción farmacológica (48,50 %). Después de la primera IVE, el 69,81 % de las mujeres utilizó métodos anticonceptivos clasificados como "muy efectivos", según la Organización Mundial de la Salud. Se identificaron como factores de riesgo de la IVE recurrente pertenecer al régimen de aseguramiento subsidiado por el Estado (Odds ratio ajustado (ORa) = 1,35; IC 95 %: 1,05-1,72) y haber tenido dos o más gestaciones (ORa = 1,23; IC 95 %: 1,06 - 1,44). Como factores protectores se identificaron: contratación del servicio de IVE bajo modalidad de pago de bolsillo (ORa = 0,71; IC 95 %: 0,61-0,82), el antecedente de IVE tardía (ORa = 0,30; IC 95 %: 0,11-0,81), y la elección del implante subdérmico posterior al primer aborto primer aborto como (ORa =0,64; IC 95 %: 0,49 - 0,83). Conclusiones: La prevalencia de IVE recurrente posiblemente está incrementando. Se requieren estudios prospectivos que evalúen si existe una tendencia al incremento y que verifiquen posibles hipótesis de asociación que surgen de este trabajo.
Objectives: To describe the prevalence of recurrent voluntary termination of pregnancy (VTP) and to explore associated factors. Material and methods: Descriptive, cross-sectional cohort study which included women seen between 2015 and 2021 in five sites of an institution located in the Department of Antioquia which promotes sexual and reproductive health (SRH) care in Colombia. Measured variables included sociodemographics, SRH, recurrent performance of VTP, type of procedure used in the first VTP and contraception method selected afterwards. The prevalence of global and yearly recurrent abortion period is presented. Associated factors were explored using a multivariate analysis. The research committee of the institution approved the study. Results: In total, 20,423 women were included. The prevalence of recurrent VTP was 4.07 % (n = 831) during the entire period, ranging between 2.3 and 6 % over the 7 years. The most commonly used method for recurrent VTP was pharmacological induction (48.50 %). After the first VTP, 69.81 % of women used contraceptive methods classified as "very effective" according to the World Health Organization. The risk factors identified as being associated with recurrent VTP included being part of the state-subsidized health insurance system (adjusted odds ratio [aOR] = 1.35; 95 % CI:1.05-1.72) and having had two or more pregnancies (aOR = 1.23; 95% CI: 1.06 - 1.44). Protective factors were identified and included out-of-pocket payment for VTP service (aOR = 0.71; 95% CI: 0.61-0.82), a history of late VTP (aOR = 0.30; 95% CI: 0.11-0.81), and the selection of a subdermal implant for contraception following the first abortion (sOR = 0.64; 95% CI: 0.49 - 0.83). Conclusions: It is possible that the prevalence of recurrent VTP is increasing. Prospective studies are required in order to determine whether there is a growing trend and to verify potential association hypotheses derived from this work.
Sujets)
Humains , Femelle , Grossesse , Avortement provoqué , Interruption légale de grossesse , Colombie , Contraception , Droits procréatifsRésumé
Purpose. The research work is aimed at studying and analyzing the onset of sexual activity and injecting drug use among young people of Melitopol (Zaporizhzhya region), which will make it possible to plan a number of preventive measures in order to prevent deviant behavior. Theoretical basis. The authors focus on the social problems associated with the late informing young people about the possible risks of early sexual relations and the use of drugs. Namely: students, young people, who move to another city or country, thus remaining without parental control. Scientific originality. This study allowed us to see the dynamics of attitudes (2010–2021) to injection drugs of boys and adolescent girls in cities with a population of up to 200 thousand (on the example of Melitopol, Zaporizhia region); track the tendency to awareness and care about your health during early sexual intercourse; plan a number of preventive measures to prevent the above phenomena. Conclusion. Young people between the ages of 13 and 15 put themselves at risk of becoming injecting drug users, getting infected with AIDS virus, Hepatitis B/C: 3,5% of those registered were infected with AIDS virus between the ages of 13 and 18; 28,5% were infected at the age of 18 – 24 years. The consumption of psychoactive substances (surfactants) from the injection form of consumption turned into a form of smoking and taking pills. Priority areas for further research have been identified: to conduct research with an interval of three years; to reach students of higher educational institutions, pupils of city colleges, with the aim of further cooperation with deans of educational institutions for holding lectures, talks, and thematic evenings for students on healthy lifestyles, AIDS virus and the dangers of psychoactive substances consumption.
Résumé
Objetivo: Analizar el efecto sobre el peso corporal de la anticoncepción hormonal continua mediante implante sub-dérmico liberador de etonogestrel (ENG) en mujeres en edad reproductiva atendidas en la consulta de planificación familiar de un hospital venezolano. Métodos: Investigación comparativa, con diseño cuasi experimental, de casos y controles, a etiqueta abierta, y prospectivo; con una muestra intencionada de 60 mujeres separadas para recibir bien sea un implante subdérmico (Implanon NXT®; casos) o un dispositivo intrauterino (DIU) de cobre (T de cobre; controles). Se evaluaron el peso corporal e índice de masa corporal antes y posterior de doce meses del uso del contraceptivo; así como las características demográficas de las usuarias, efectos adversos y efectividad anticonceptiva de cada método. Resultados: Luego de un año con el implante de ENG no se encontraron variaciones significativas respecto a las mediciones iniciales del peso corporal (61,21±8,30 vs. 61,23±9,50, p>0,5) e IMC (25,23±3.89 vs. 25,26 ±4,30; p>0,05); contrariamente, a lo observado entre las usuarias del DIU donde tanto el peso corporal como el IMC tuvieron un aumento significativo (P<0,05). Asimismo, la mayoría de las usuarias se mantuvieron en el mismo rango de peso donde se encontraban al iniciar el método (p<0,001); mientras que la ganancia ponderal fue mayor entre las usuarias del DIU (1,530±2,04 vs. 3,700±3,02; p<0,05). Conclusiones: El implante de ENG no produce aumento del peso corporal luego de 12 meses de uso, con mínimos efectos adversos y alta efectividad contraceptiva.
Aim: To analyse the effect on body weight of continuous hormonal contraception by releasing subdermal implant etonogestrel (ENG) in women of reproductive age treated in the family planning consultation of a Venezuelan hospital. Methods: Comparative and applied research, with quasiexperimental, case-control, open label and prospective design, with an intentional sample of 60 women separated to receive the contraceptive implant (Implanon NXT®; cases) or a cooper intrauterine device (IUD) (Cooper T; controls) was carried out. Body weight and body mass index were evaluated before and after 12 months of contraceptive use; as well as demographic characteristics of users, side effects, and contraceptive effectiveness of each method. Results: After one year with the ENG implant, no significant variations were found with respect to initial measurements of body weight (61.21±8.30 vs. 61.23±9.50, p>0.5) and BMI (25.23±3.89 vs 25.26±4.30; p>0.05); on the contrary, to what was observed among IUD users where both body weight and BMI had a significant increase (P<0.05). Likewise, most users remained in the same weight range as when starting the method (p<0.001); while weight gain was greater among IUD users (1,530±2.04 vs. 3,700±3.02; p<0.05). Conclusions: The ENG implant does not produce an increase in body weight after 12 months of use, with minimal adverse effects and high contraceptive efficacy.
Résumé
Introducción: En los países en vías de desarrollo, la existencia de barreras de acceso de las mujeres a la anticoncepción genera baja adherencia al uso de los diferentes métodos anticonceptivos. Objetivo: Describir la adherencia y barreras en el uso los métodos anticonceptivos en una población de mujeres adultas. Metodología: Estudio cuantitativo, observacional, descriptivo de corte trasversal, con una muestra no probabilística de mujeres mayores de 18 años atendidas en un centro de salud de primer nivel, a quienes se aplicó criterios de selección y se obtuvo consentimiento voluntario para su participación. El estudio siguió los principios de Helsinki y contó con la aprobación del Comité de Ética de la Sociedad Peruana de Obstetricia y Ginecología. El instrumento utilizado fue el IRB Study (Barriers to adolescent contraception adherence) con una consistencia Alfa de Cronbach de 0,79. Se usó estadística descriptiva y la prueba exacta de Fisher para el análisis bivariado. Resultados: Participaron 353 mujeres, la edad media fue 24,6 ± 4,2 años. El 65,7 % fueron solteras y 19,5 % convivientes; el 58,4 % refirió nivel de estudios universitarios; el 73,7 % son de religión católica frente al 26,3% de evangélicos. Los métodos más usados fueron el condón masculino con 37,2 % y las píldoras orales con 23%. Los principales obstáculos fueron el temor por los efectos colaterales de los anticonceptivos con 66,2% y el desplazamiento al centro de salud para su control con 23,5 %. Discusión: La edad y la práctica de actividad sexual son factores que estuvieron vinculados a la adherencia de los anticonceptivos. La preocupación por el aumento de peso, sangrado y riesgo para la salud fueron las principales barreras.
Introduction: In developing countries, the existence of barriers to women's access to contraception generates low adherence to the use of different contraceptive methods. Objective: To describe the adherence and barriers in the use of contraceptive methods in a population of adult women. Methods: Quantitative, observational, descriptive, cross-sectional study, with a non-probabilistic sample of women over 18 years of age attended at a first level health center, to whom selection criteria were applied and voluntary consent was obtained for their participation. The study followed the Helsinki principles and was approved by the Ethics Committee of the Peruvian Society of Obstetrics and Gynecology. The instrument used was the IRB Study (Barriers to adolescent contraception adherence) with a Cronbach Alpha consistency of 0.79. Descriptive statistics and Fisher's exact test were used for bivariate analysis. Results: A total of 353 women participated, the mean age was 24.6 ± 4.2 years; 65.7% were single and 19.5% were cohabiting; 58.4% reported university education; 73.7% were Catholic compared to 26.3% Evangelical. Male condoms (37.2%) and oral pills (23%) were the most commonly used methods. Fear of the side effects of contraceptives (66.2%) and travel to the health center for control (23.5%) were the main obstacles. Discussion: Age and sexual activity were factors associated with contraceptive adherence. Concern about weight gain, bleeding and health risk were the main barriers.
Résumé
Objetivo: Analisar o impacto orçamentário da adoção de dispositivos contraceptivos reversíveis de longa duração em uma operadora de plano de saúde localizada no Sul do Brasil. Especificamente, analisamos a incorporação do implante subdérmico de etonogestrel (Implanon®) como alternativa ao sistema intrauterino de levonorgestrel (DIU Mirena® ou DIU Kyleena®), ao longo de um período de 15 anos. Métodos: Realizamos uma análise do impacto orçamentário incremental, considerando a inclusão gradual do implante subdérmico de etonogestrel. Foram considerados dados de uma operadora de planos de saúde com mais de 600.000 beneficiários. O horizonte temporal de 15 anos permitiu uma avaliação abrangente dos efeitos financeiros. Resultados: Identificamos 5.345 pacientes elegíveis para a utilização de contraceptivos reversíveis de longa duração. No cenário em que somente o sistema intrauterino de levonorgestrel era adotado, projetou-se um impacto orçamentário total de R$ 746.379.857,80 ao longo de 15 anos. No cenário alternativo, com a incorporação gradual do implante subdérmico, o impacto orçamentário total foi calculado em R$ 689.800.196,83. Isso resultou em um impacto orçamentário incremental negativo de -R$ 56.579.660,97 ao longo do período. Conclusão: A análise de impacto orçamentário realizada indica um potencial benefício financeiro ao adotar o implante subdérmico de etonogestrel como alternativa ao sistema intrauterino de levonorgestrel para contracepção. Esse achado sugere possíveis reduções de custos na área de saúde suplementar no Brasil, reforçando a importância de avaliar opções economicamente viáveis.
Objective: To analyze the budgetary impact of the adoption of long-acting reversible contraceptive devices in a health plan operator located in southern Brazil. Specifically, we analyzed the incorporation of the etonogestrel subdermal implant (Implanon®) as an alternative to the levonorgestrel intrauterine system (Mirena® IUD or Kyleena® IUD), over a period of 15 years. Methods: We performed an analysis of the incremental budgetary impact, considering the gradual inclusion of the etonogestrel subdermal implant. Data from a health plan operator with more than 600,000 beneficiaries were considered. The 15-year time horizon allowed for a comprehensive assessment of the financial effects. Results: We identified 5,345 patients eligible for the use of long-acting reversible contraceptives. In the scenario where only the levonorgestrel intrauterine system was adopted, a total budget impact of BRL 746,379,857.80 was projected over 15 years. In the alternative scenario, with the gradual incorporation of the subdermal implant, the total budgetary impact was calculated at BRL 689,800,196.83. This resulted in a negative incremental budgetary impact of -R$56,579,660.97 over the period. Conclusion: The budget impact analysis carried out indicates a potential financial benefit in adopting the etonogestrel subdermal implant as an alternative to the levonorgestrel intrauterine system for contraception. This finding suggests possible cost reductions in the supplementary healthcare area in Brazil, reinforcing the importance of evaluating economically viable options.
Sujets)
Analyse coût-bénéfice , Contraception , Implant pharmaceutique , Évaluation du Coût-EfficacitéRésumé
Objetivo: Analisar o uso dos contraceptivos hormonais em mulheres com asma e a escolha desses métodos contraceptivos para essa população, com avaliação de eventuais repercussões sobre novos episódios de asma e sibilos. Métodos: Foram selecionados estudos longitudinais, ensaios clínicos, revisões sistemáticas e metanálises. As plataformas consultadas foram PubMed, Embase, Cochrane e SciELO, com a utilização dos descritores: "contracepção", "contracepção hormonal", "sistema intrauterino liberador de levonorgestrel" e "asma". Resultados: Dois grandes estudos demonstraram que o uso de contraceptivos hormonais esteve associado à redução do risco de novos episódios de asma. Uma revisão sistemática concluiu que os resultados para o uso de contraceptivos hormonais para mulheres com asma foram mistos, com aumento ou redução dos seguintes riscos: novo episódio de asma e aumento da frequência das crises e dos sibilos. O uso da contracepção hormonal em pacientes obesas portadoras de asma é controverso. Conclusão: Os resultados para o uso de contraceptivos hormonais em mulheres com asma são inconsistentes, com relatos de aumento ou de redução do risco de novos episódios. O uso do método contraceptivo deve ser discutido individualmente, levando-se em consideração outros fatores de risco associados e o desejo da mulher. A paciente deverá ser orientada se houver piora dos sintomas clínicos de asma na vigência do uso de qualquer método contraceptivo hormonal.
Objective: To analyze the use of hormonal contraceptives in women with asthma and the choice of this contraceptive method for this population, evaluating possible repercussions on new episodes of asthma and wheezing. Methods: Longitudinal studies, clinical trials, systematic reviews and meta-analyses were selected. Platforms consulted: PubMed, Embase, Cochrane, SciELO, using the descriptors: "contraception", "hormonal contraception", "levonorgestrel-releasing intrauterine system" and "asthma". Results: Two large studies demonstrated that the use of hormonal contraceptives was associated with a reduced risk of new episodes of asthma. A systematic review concluded that the results for the use of hormonal contraceptives for women with asthma were mixed, with increased or decrease in the following risks: new asthma episodes, increased frequency and wheezing. The use of hormonal contraception in obese patients with asthma is controversial. Conclusion: The results for the use of hormonal contraceptives in women with asthma are inconsistent, with reports of increased or reduced risk of new episodes. The use of the contraceptive method should be discussed individually, taking into account other associated risk factors and the woman's desire. The patient will be advised if there is a worsening of the clinical symptoms of asthma while using any hormonal contraceptive method.
Sujets)
Humains , Femelle , Adolescent , Adulte , Asthme/complications , Contraceptifs hormonaux/effets indésirables , Contraceptifs hormonaux/usage thérapeutique , Progestérone/effets indésirables , Signes et symptômes respiratoires , Douleur thoracique/diagnostic , Ménarche , Bruits respiratoires/diagnostic , Études transversales , Études de cohortes , Études longitudinales , Toux/diagnostic , Dyspnée/diagnostic , Oestrogènes , Revue systématique , Poumon/physiopathologieRésumé
Medical abortions have been a national as well as social concern for the society, especially in India. There have been certain laws, acts and amendments that have been designed to promote safe abortions. Despite, the rules in place, there is still need to have more awareness as the women still face difficulties in accessing abortion services. The reasons may include legal hurdles, stigma, financial concerns and many more. Through this article, we would like to emphasize the role of government, medical professionals, health care providers to come together and form more dependable guidelines that may help women to access safer abortions.
Résumé
A decisão de escolha do método contraceptivo em situações clínicas especiais é desafiadora tanto para médicos quanto para pacientes. Em parte, isso se deve às contraindicações reais que alguns contraceptivos apresentam. Porém, há uma estreita relação com a falta de conhecimento e medo de muitos profissionais em prescrever métodos que, na realidade, são seguros. A má escolha do método contraceptivo para pacientes portadoras de condições específicas pode levar a diversos desfechos ruins, como piora da condição de base, ocorrência de eventos adversos indesejáveis e preveníveis e ocorrência de gravidez de alto risco indesejada. Dessa forma, foi realizada uma revisão na literatura com o objetivo de auxiliar profissionais médicos na decisão contraceptiva de pacientes portadoras de doenças reumatológicas e musculoesqueléticas, epilepsia, esclerose múltipla, transtornos alimentares, anemia falciforme e obesidade, e que já foram submetidas a cirurgia bariátrica.(AU)
The decision to choose the contraceptive method in special clinical situations is challenging for both physicians and patients. In part, this is due to the real contraindications that some contraceptives present. However, there is a close relationship with the lack of knowledge and fear of many professionals in prescribing methods that are actually safe. The poor choice of contraceptive method in patients with specific conditions can lead to several bad outcomes, such as worsening of the baseline condition, occurrence of undesirable and preventable adverse events and occurrence of an unwanted high-risk pregnancy. Thus, a literature review was carried out in order to assist medical professionals in the contraceptive decision of patients with rheumatological and musculoskeletal diseases, epilepsy, multiple sclerosis, eating disorders, sickle cell anemia, obesity and who have already undergone bariatric surgery.(AU)
Sujets)
Humains , Femelle , Grossesse , Contraception/effets indésirables , Contraception/méthodes , Rhumatismes , Santé des femmes , Personnel de santé , Épilepsie , Planification du développement familialRésumé
Resumen Antecedentes: En México los embarazos adolescentes son 77 por cada 1,000. De los nacimientos anuales, el 17% son de madres adolescentes, con casi 350,000. Objetivo: Explicar por qué las adolescentes se embarazan a pesar del conocimiento de métodos anticonceptivos. Métodos: Con un estudio exploratorio y observacional, se evaluaron a 300 adolescentes embarazadas de 15 a 19 años, que no tenían antecedentes de consumo de sustancias adictivas y cuyos embarazos no fueron resultado de una violación.. Se aplicó el cuestionario de funcionamiento familiar y una entrevista de los antecedentes sociodemográficos. Resultados: El inicio de vida sexual fue a los 12 años para el 1.7%, de las participantes, a los 13 para el 7.3%, a los 14 para el 18.7%, a los 15 para el 36%, a los 16 para el 19.3% y las restantes (17%) tuvieron un inicio a los 19 años. El 100% manifestó que conocía métodos anticonceptivos, incluyendo la píldora del día siguiente. Conclusiones: El embarazo a temprana edad viene acompañado de mitos sociales e individuales sobre el conocimiento de la sexualidad humana, la anticoncepción y la vida amorosa. El embarazo representa para las jóvenes tener un objeto de amor y obtener un lugar en el mundo y dentro sus familias.
Abstract Background: In Mexico, teenage pregnancy is 77 for every 1,000. In terms of annual births, 17% are from teenage mothers, which are almost 350,000. Objective: To explain why teenage girls get pregnant in spite of knowing about contraceptives. Method: An observational and exploratory study by which 300 pregnant teenage girls between 15 and 19 years old were evaluated, with no history of substance abuse and whose pregnancies were not the result of rape. A questionnaire on family dynamics and an interview about their sociodemographic background were applied. Results: The first sexual intercourse for 1.7% of the participants was at 12 years old; for 7.3%, at 13; for 18.7%, at 14; for 36%, at 15; for 19.3%, at 16, and for the remaining 17%, near 19 years old. All of them (100%) stated they knew about contraceptives, including the morning-after pill. Conclusions: Pregnancies at an early age come with individual and social myths about the knowledge of human sexuality, contraception, and love life. For these young women, a pregnancy represents an object of love and obtaining a place in the world and within their families.
Résumé
Introducción: El embarazo en la adolescencia es un problema de salud pública en Perú; sin embargo, hay una cifra de adolescentes con vida sexual activa, sin protección anticonceptiva. Objetivo: Determinar los factores socioculturales, sexuales y reproductivos asociados al no uso de métodos anticonceptivos en adolescentes mujeres. Métodos: Investigación descriptiva, transversal; se aplicó un análisis de base secundaria de la Encuesta Demográfica y Salud Familiar realizada en Perú en 2019. La población estuvo conformada por 1 871 mujeres de 15 a 19 años y se excluyeron aquellas que no habían iniciado su vida sexual o con datos incompletos. Se utilizó prueba ji cuadrado de Pearson y regresión de Poisson para el análisis estadístico. Resultados: El 46,6 % de adolescentes no utilizaron métodos anticonceptivos. Se asociaron al no uso de métodos anticonceptivos, factores socioculturales como edad de 15 a 17 años, nivel educativo superior, asistencia actual a institución educativa, razón para dejar de estudiar (p< 0,05); y factores sexuales y reproductivos como: no tener parejas sexuales actualmente, edad de la primera relación sexual entre 15 a 19 años, no tener hijos y no vivir con una pareja (p< 0,05). Según el análisis multivariado, tener 15 a 17 años aumenta la prevalencia de no usar métodos anticonceptivos (Rpa: 1,21 IC: 1,09-1,33). Sin embargo, tener parejas sexuales (Rpa: 0,48 IC: 0,44-0,52) e hijos (Rpa: 0,49 IC: 0,45-0,55) redujeron la prevalencia de no uso de anticonceptivos. Conclusiones: Los factores socioculturales, sexuales y reproductivos asociados al no uso de anticoncepción fueron la edad de 15 a 17 años, tener parejas sexuales e hijos.
Introduction: Teenage pregnancy is a public health problem in Peru; however, there is a number of sexually active adolescents without contraceptive protection. Objective: To determine the sociocultural, sexual and reproductive factors associated with the non-use of contraceptive methods in female adolescents. Methods: Descriptive, cross-sectional research; a secondary base analysis of the Demographic and Family Health Survey carried out in Peru, 2019 was applied. The population consisted of 1871 women between the ages of 15 to 19 years and those who had not started their sexual life or with incomplete data were excluded. Pearson's ji-square test and Poisson Regression were used for statistical analysis. Results: 46,6 % of adolescents did not use contraceptive methods. Non-use of contraceptive methods was associated with sociocultural factors such as age between 15 to 17 years, higher educational level, current attendance at an educational institution, reason for leaving school (p< 0,05); and sexual and reproductive factors such as: not currently having sexual partners, age of first sexual intercourse between 15 and 19 years, not having children and not living with a partner (p< 0,05). According to the multivariate analysis, being 15 to 17 years old increases the prevalence of not using contraceptive methods (RPa: 1,21 CI: 1,09-1,33). However, having sexual partners (RPa: 0,48 CI: 0,44-0,52). However, having sexual partners (RPa: 0,48 CI: 0,44-0,52) and children (RPa: 0,49 CI: 0,45-0,55) reduced the prevalence of non-use of contraceptives. Conclusions: The sociocultural, sexual and reproductive factors associated with the non-use of contraception were the age of 15 to 17 years, having sexual partners and children.